Patent · US Active

ALK protein regulator and anti-tumor application thereof

US12390532B2 · kind B2 · utility

0Cited by

1References

9Claims

0Family size

Assignee

SHANGHAITECH UNIVERSITY · CN

Inventors

Xiaobao Yang · New York, US
Biao Jiang · Shanghai, CN
Xiaoling Song · Woodinville, US
Ning Sun · Fremont, US
Chaowei Ren · Zhuqiao, CN
Ying Kong · Shanghai, CN
Jianshui Zhang · Zhuqiao, CN
Jinju Chen · Shanghai, CN
Yan Li · Tallahassee, US
Yuedong Zhou · Shanghai, CN

Key dates

Filing date	Jun 11, 2020
Grant date	Aug 19, 2025
Priority date	—
Expiry date	Sep 30, 2042

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F9/65583
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of general formula (I), a compound of general formula (III) and anti-tumor applications thereof. A series of compounds designed and synthesized have a wide range of pharmacological activities, have the function of degrading specific proteins and/or inhibiting activity, and can be used in related tumor and cancer treatments.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.